All In Biotech

Drug Trial Radar · NCT04430790

Doxapram Therapy in Preterm Infants (DOXA Trial)

Doxapram Versus Placebo in Preterm Newborns: An International Double Blinded Multicenter Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Apr 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 396 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

396

Planned (sponsor's estimate)

Start

Jun 15, 2020

Primary completion

May 1, 2026

Study completion May 1, 2034

Sponsor

Lead sponsor
Erasmus Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Nederlands Neonataal Netwerk (N3), the Netherlands; Universitaire Ziekenhuizen KU Leuven; Maternal, Infant, Child and Youth Research Network (MICYRN)
First posted
Jun 12, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 23 weeks, up to 29 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Preterm infants often suffer from apnea of prematurity (AOP; a cessation of breathing) due to immaturity of the respiratory system. AOP can lead to oxygen shortage and a low heart rate which might harm the development of the newborn, especially the central nervous system. In order to prevent oxygen shortage, infants are treated with non-invasive respiratory support and caffeine. Despite these treatments, many preterm newborns still suffer from AOP and need invasive mechanical ventilation. Although this will result in complete resolution of AOP, invasive mechanical ventilation has the disadvantage of being a major risk of chronic lung disease and impaired neurodevelopmental outcome. Restrictive invasive ventilation is therefore advocated nowadays in preterm infants. Doxapram is a respiratory stimulant that has been administered off-label to treat AOP. Doxapram, as add-on treatment, seems to be effective in treating AOP and to prevent invasive mechanical ventilation. It is unclear if a preterm infant benefit from doxapram treatment on the longer term. This study compares doxapram to placebo and hypothesizes that doxapram will protect preterm infants from both invasive ventilation (and related lung disease) and AOP related oxygen shortage (and related impaired brain development).

Conditions

  • Apnea of Prematurity
  • Respiratory Insufficiency

Interventions

  • DoxapramDrug

    Loading dose and continuous doxapram infusion.

  • PlaceboDrug

    Loading dose and continuous placebo infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Death or severe disabilityTime frame: 2 years corrected age

Locations

24 sites in 3 countries. Site status is shown where the registry gives one.

  • Sint Augustinus Hospital Antwerp

    Antwerp, Belgium · Recruiting

  • University Hospital Antwerp

    Antwerp, Belgium · Recruiting

  • Chirec-Delta Hospital

    Brussels, Belgium · Recruiting

  • University Hospitals Leuven

    Leuven, Belgium · Recruiting

  • St Luc Louvain

    Brussels, Avenaue Hippocrate 10, Belgium · Recruiting

  • Delta Hospital Brussels

    Brussels, Brussels Capital, Belgium · Recruiting

  • University Hospital Brussels

    Jette, Brussels Capital, Belgium · Recruiting

  • Grand Hospital de Charleroi

    Charleroi, Henegouwen, Belgium · Recruiting

  • Clinique Saint-Vincent Liege

    Liège, Liege, Belgium · Suspended

  • Academisch Ziekenhuis Sint-Jan

    Bruges, West-Vlaanderen, Belgium · Recruiting

  • Foothills Medical Centre

    Calgary, Alberta, Canada · Not yet recruiting

  • Royal Alexandra Hospital

    Edmonton, Alberta, Canada · Not yet recruiting

  • McMaster Children's Hospital

    Hamilton, Ontario, Canada · Not yet recruiting

  • Montreal Children's Hospital

    Montreal, Quebec, Canada · Not yet recruiting

  • Centre Mère-Enfent Soleil

    Québec, Quebec, Canada · Not yet recruiting

  • University Medical Center Groningen

    Groningen, Netherlands · Recruiting

  • UMC Utrecht - Wilhelmina Kinderziekenhuis

    Utrecht, Netherlands · Recruiting

  • Radboudumc Amalia Children's Hospital Nijmegen

    Nijmegen, Gelderland, Netherlands · Recruiting

  • Maastricht University Medical Center

    Maastricht, Limburg, Netherlands · Recruiting

  • Maxima Medical Center Veldhoven

    Veldhoven, North Brabant, Netherlands · Recruiting

  • Amsterdam University Medical Center

    Amsterdam, North Holland, Netherlands · Recruiting

  • Isala Clinics Zwolle

    Zwolle, Overijssel, Netherlands · Recruiting

  • Leiden University Medical Center

    Leiden, South Holland, Netherlands · Recruiting

  • Erasmus Medical Center - Sophia Children's Hospital

    Rotterdam, South Holland, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.